Bullish Moving Averages
13
Bearish Moving Averages
3
Back Stocks profile
Stock analysis tool for investors
Performance
Open Price
22.30Prev. Close
21.2200Volume
32000.00Value
771200.00Fundamentals
Market Cap
10.40
Price to Earnings
0.00
Price to Book Value
1.10
Dividend Yield
0.00
PE to Growth
0.00
Op Revenue TTM
0.00
Net Profit TTM
0.00
Cash From Operating Activity
-0.22
Return on Equity %
6.47
EMA & SMA
DELIVERY AND VOLUME
DAILY AVG. DELIVERY VOLUME %
05 Jul, 2024
62.5
Week
64.3
Month
LEGEND
Positive Indicator
Neutral Indicator
Negative Indicator
RESISTANCE AND SUPPORT
23.52
PIVOT
First Resistance
24.78
Second Resistance
25.45
Third Resistance
26.71
First Support
22.85
Second Support
21.59
Third Support
20.92
Relative Strength Index
61.53
Money Flow Index
72.94
MACD
0.78
MACD Signal
0.54
Average True Range
1.12
Average Directional Index
8.82
Rate of Change (21)
20.5
Rate of Change (125)
-19.67
Commodity Channel Index
115.7
Williams %R
-2.5
BETA
1 Month
1.27
3 Month
0.65
1 Year
0.34
3 Year
PRICE CHANGE ANALYSIS
↑ 2.55%
1 Week
Low
High
22.27
24.2
↑ 7.93%
1 Month
Low
High
20.15
24.2
↑ 26.44%
3 Months
Low
High
19.8
24.2
↑ 0.42%
6 Months
Low
High
15.68
24.86
↓ -3.6%
1 Year
Low
High
15.68
35
30 May 2024
Dr Lalchandani Labs Ltd - 541299 - Board Meeting Outcome for Audited Standalone Financial Statement Of The Company For The Half Year And Year Ended March 2024
Audited standalone Financial results of the Company for the Financial year ended March 2024
30 May 2024
Dr Lalchandani Labs Ltd - 541299 - Audited Standalone Financial Statements Of The Company For The Half Year And Year Ended March 2024
Audited standalone financial statements of the Company for the half year and year ended March 2024
18 May 2024
Dr Lalchandani Labs Ltd - 541299 - Board Meeting Intimation for Consideration Of Audited Financial Statement For The Half Year And Year Ended March 31, 2024
Dr Lalchandani Labs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2024 ,inter alia, to consider and approve Approval of Financial statement for the year ended March 31, 2024
02 May 2024
Dr Lalchandani Labs Ltd - 541299 - Appointment of Company Secretary and Compliance Officer
Appointment of Ms. Namita Anand as Company Secretary and Compliance officer of the Company
20 Apr 2024
Dr Lalchandani Labs Ltd - 541299 - Compliance Certificate Under Regulation 40(10) Of SEBI (LODR) Regulations, 2015
compliance certificate under Reg 40(10) for the quarter ended March 2024
17 Apr 2024
Dr Lalchandani Labs Ltd - 541299 - Compliance Certificate Under Regulation 7(3) Of SEBI (LODR) Regulations For The Year Ended March 2024
Compliance Certificate for the year ended March 2024
15 Apr 2024
Dr Lalchandani Labs Ltd - 541299 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Certificate by RTA under Reg 74(5) for the quarter ended March, 2024
10 Apr 2024
Dr Lalchandani Labs Ltd - 541299 - Reply To The Clarification Sought Dated April 09, 2024
Reply to the clarification sought
